Akari Therapeutics ADR (AKTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 0 | 4,594 | 5,816 | 5,244 | 5,872 |
| Operating Income | N/A | -4,594 | -5,816 | -5,244 | -5,872 |
| Other Income | 0 | 5,595 | 136 | 68 | 84 |
| Pre-tax Income | 0 | 1,001 | -5,680 | -5,176 | -5,788 |
| Net Income Continuous | N/A | 1,001 | -5,680 | -5,176 | -5,788 |
| Net Income | $N/A | $1,001 | $-5,680 | $-5,176 | $-5,788 |
| EPS Basic Total Ops | N/A | 0.27 | -1.92 | -1.92 | 5.86 |
| EPS Basic Continuous Ops | N/A | 0.27 | -1.91 | -1.93 | -2.20 |
| EPS Diluted Total Ops | N/A | 0.27 | -1.92 | -1.92 | 5.86 |
| EPS Diluted Continuous Ops | N/A | 0.27 | -1.91 | -1.93 | -2.20 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -2.00 | -2.20 | -2.40 |
| EBITDA(a) | $N/A | $-4,593 | $-5,815 | $-5,243 | $-5,871 |